ReviewFrontiers in immunology2021

Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?

Shankun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.